博晖创新(300318) - 2024 Q1 - 季度财报

Financial Performance - The company's revenue for Q1 2024 was CNY 262,051,377.78, representing a 3.60% increase compared to CNY 252,950,995.14 in the same period last year[5] - Net profit attributable to shareholders was CNY 19,863,584.33, a significant increase of 283.90% from CNY 5,174,206.08 year-on-year[5] - The net profit for Q1 2024 was CNY 42,022,580.71, significantly up from CNY 9,672,620.16 in Q1 2023, marking an increase of 335.5%[28] - Basic and diluted earnings per share were both CNY 0.0243, up 285.71% from CNY 0.0063 in the previous year[5] - The total comprehensive income for the first quarter of 2024 was CNY 41,913,382.88, compared to CNY 9,156,153.67 in the same period last year, representing a significant increase[29] - The net profit attributable to the parent company was CNY 19,754,270.80, up from CNY 4,655,451.57 year-over-year[29] Cash Flow and Liquidity - The net cash flow from operating activities reached CNY 31,910,106.63, marking a 516.83% increase compared to CNY 5,173,217.62 in Q1 2023[5] - Cash flow from operating activities generated a net cash inflow of CNY 31,910,106.63, compared to CNY 5,173,217.62 in the prior year, reflecting a strong operational performance[32] - Total cash inflow from financing activities was CNY 281,668,207.13, down from CNY 693,022,700.66 in the previous year, indicating a decrease in financing activities[33] - The cash and cash equivalents at the end of the period were CNY 69,469,073.15, a decrease from CNY 87,292,850.77 at the end of the previous year[33] - The company reported a cash outflow from investing activities of CNY 72,546,642.65, compared to CNY 65,388,409.04 in the same period last year, indicating increased investment expenditures[32] Assets and Liabilities - Total assets at the end of Q1 2024 were CNY 3,984,606,786.57, reflecting a 1.49% increase from CNY 3,926,015,273.52 at the end of the previous year[5] - The total liabilities rose to CNY 1,602,148,374.52, compared to CNY 1,585,470,244.35, an increase of 1.7%[24] - The company’s equity attributable to shareholders increased to CNY 1,389,292,813.18 from CNY 1,369,538,542.38, showing a growth of 1.4%[25] Expenses - Management expenses rose by 33.44% to CNY 40,429,092.55, mainly due to increased material consumption and asset write-offs[10] - The company experienced a 119.27% increase in income tax expenses, totaling CNY 7,808,401.64, driven by growth in revenue and gross profit[10] - Research and development expenses for the quarter were CNY 14,556,648.09, slightly up from CNY 14,197,200.03, indicating a focus on innovation[26] Shareholder Information - Total number of common shareholders at the end of the reporting period is 37,809[13] - The largest shareholder, Du Jiangtao, holds 39.03% of shares, totaling 318,811,388 shares[14] - The company has a total of 10 major shareholders, with the top two being spouses, indicating potential related party transactions[14] Investments and Projects - The company approved a total guarantee amount of up to RMB 1.2 billion for subsidiaries, with RMB 400 million specifically for Hebei Bohui[17] - The company signed a cooperation framework agreement to invest RMB 3.3 billion in the "Bohui Biological Modern Pharmaceutical Industry Base" project in Shijiazhuang[19] Inventory and Receivables - Accounts receivable decreased from RMB 53,895,164.57 to RMB 46,551,141.37 during the reporting period[22] - Inventory increased from RMB 854,562,676.21 to RMB 888,169,192.26[22] - The company has signed four receivables guarantee agreements with Zheshang Bank, with a total guarantee amount of RMB 45.496 million[16] Sales Performance - The company’s total revenue from sales of goods and services was CNY 270,726,895.88, compared to CNY 258,419,243.49 in the previous year, showing a growth in sales[31] - The total operating revenue for Q1 2024 was CNY 262,051,377.78, an increase of 3.4% compared to CNY 252,950,995.14 in the same period last year[26] - The total operating costs decreased to CNY 214,677,513.06 from CNY 241,498,331.27, representing a reduction of approximately 11.1%[26] - The company reported a gross profit margin of approximately 18.1% for Q1 2024, compared to 12.5% in the previous year[26]